Skip to main content
Caplight Logo









Novogaia

Novogaia

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.novogaia.bio/

Last Round

Seed

Jan 1, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Novogaia is a biotechnology company that develops new medicines from fungi using artificial intelligence to decode drug-like molecular structures.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Foundation

Keywords

AI drug discoveryAI biotechnatural product discoverydrug discovery platformfungal-derived therapeuticsfoundation modelfrontier AI labin silico drug discoverygenerative biologymolecular structure predictionmass spectrometryautoimmunity therapeuticscomp biometabologenomicspharmaceutical partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novogaia Comparables

Compare Novogaia with similar companies based on industry and business-model similarity.

Novogaia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kapoose Creek Bio
83%
LifeMine Therapeutics
79%
Simplicia, Inc.
78%

Novogaia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 1, 2026

Key People

Founding team and executive leadership

Tess Bevers

Co-founder & CEO

Founding Team

Novogaia Investors

Notable investors and investment history

Novogaia investors
InvestorRounds
Backed VCSeed
Entrepreneurs FirstAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Raised a seed round with Backed VC and Entrepreneurs First.

  • Oct 3, 2024

    Monthly visitors increased 525% MoM, reaching 394.

Novogaia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Novogaia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novogaia's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range6
Year Founded2024
Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?